BRCA2 and neoplasm: In addition to the excellent therapeutic response achieved due to the finding of the BRCA2 mutation in the somatic tumour DNA and the respective change of therapeutic regimen, this finding also allowed subsequent confirmation of its germline origin and genetic counselling for the patient and her family.